Director, CMC Regulatory Affairs
Company: Capricor Therapeutics
Location: San Diego
Posted on: February 19, 2026
|
|
|
Job Description:
Job Description Job Description Capricor Therapeutics (NASDAQ:
CAPR) is a biotechnology company dedicated to advancing
transformative cell and exosome-based therapies for rare diseases.
At the forefront of our innovation is Deramiocel ( CAP-1002 ), our
lead cell therapy in late-stage development for Duchenne muscular
dystrophy. We are also harnessing our proprietary StealthX™ exosome
platform to unlock new possibilities in targeted delivery and
vaccinology. Every program reflects our commitment to pushing the
boundaries of science and delivering life-changing treatments to
patients and families who need them most. The Director, CMC
Regulatory Affairs provides strategic leadership and ownership of
Chemistry, Manufacturing, and Controls (CMC) regulatory activities
across Capricor’s product lifecycle, with primary accountability
for Deramiocel’s BLA pathway and advancement of other pipeline
candidates from development through potential commercial approval
and post-approval maintenance. Reporting to and collaborating
closely with the VP of Regulatory Affairs, this role develops and
executes CMC regulatory strategy, ensures compliance with global
requirements (FDA, ICH, EMA), identifies and mitigates risks, and
partners with cross-functional teams (CMC Development,
Manufacturing, Quality, MSAT, Supply Chain, and others) to drive
successful submissions, health authority interactions, and company
objectives in a fast-paced, mission-driven biotech environment.
Responsibilities Develop, own, and execute CMC regulatory strategy
across the product lifecycle (from development through commercial
and post-approval phases) in alignment with global regulatory
requirements and Capricor’s overall regulatory and business goals.
Oversee and lead the preparation, authoring, review, final
approval, compilation, and submission of CMC sections for major
regulatory filings (e.g., IND amendments, BLA modules, supplements,
annual reports, MAAs, responses to queries/information requests,
and post-approval changes). Proactively identify risks related to
documentation, content, quality, or timelines for global CMC
submissions; collaborate with Manufacturing, Quality, Process
Development, MSAT, and other departments to ensure timely delivery
of approved, high-quality technical source documents. Review and
approve CMC-related documentation requiring Regulatory Affairs
input, including change controls, regulatory impact assessments,
technical reports, stability protocols, process validation
summaries, comparability protocols, and deviation/investigation
reports. Foster CMC regulatory alignment and phase-appropriate
readiness by collaborating with supporting departments
(Manufacturing, Quality Assurance, MSAT, Supply Chain, Commercial,
etc.) to support development, scale-up, validation, and commercial
readiness activities. Review and approve product labeling with
responsibility for CMC-related claims, product descriptions,
manufacturing statements, and participate in Advertising &
Promotion review committees as needed. Manage, mentor, and develop
regulatory affairs professionals; provide leadership, oversight,
accountability, and support to ensure high-performance deliverables
and team growth. Serve as the primary CMC interface with health
authorities (primarily FDA for biologics/cell therapies,
potentially EMA) for submissions, negotiations, formal meetings
(e.g., Type meetings, pre-BLA interactions), and responses to
queries or deficiencies (including addressing any CMC-related items
from the Deramiocel CRL). Monitor global regulatory trends,
guidelines, and precedents (e.g., ICH Q updates, FDA guidance on
CMC for cellular/gene therapies, advanced therapies) and adapt
Capricor’s CMC strategies proactively to maintain compliance and
competitive advantage. Contribute to regulatory risk assessments,
gap analyses, contingency planning, and inspection readiness for
CMC aspects and manufacturing sites. Perform such other duties as
may be assigned from time to time. Requirements Bachelor’s degree
in Pharmacy, Chemistry, Chemical Engineering, Life Sciences, or a
closely related field; advanced degree (e.g., MS, PhD, PharmD)
preferred. 8 years of experience in regulatory affairs with a
strong CMC focus in the pharmaceutical/biotech industry, including
significant experience with biologics, cell therapies, or
regenerative medicine products; commercial-stage product experience
(post-approval lifecycle management) highly preferred. Proven track
record of preparing, authoring, leading, and submitting CMC
sections for major regulatory filings (e.g., IND, BLA, NDA, MAA,
supplements) to FDA and/or EMA, including successful responses to
agency queries, deficiencies, or Complete Response Letters.
In-depth knowledge of global regulatory requirements and guidelines
relevant to CMC for biologics and cell therapies (e.g., ICH Q8-Q12,
FDA guidance on CMC for cellular therapies, process validation,
stability, comparability, potency assays). Experience supporting
BLA or similar submissions for advanced therapy products, with
familiarity in addressing CMC issues in late-stage reviews or
post-CRL scenarios preferred. Strong project management skills with
the ability to lead multiple complex projects, manage timelines,
resources, and cross-functional dependencies in a dynamic
environment. Exceptional communication skills (written and verbal)
for effective interaction with internal teams, external partners,
and health authorities, including authoring clear regulatory
documents and presenting strategies. Proficiency in regulatory
information management systems and tools (e.g., Veeva RIM, document
authoring/publishing software). Demonstrated leadership abilities,
including mentoring and developing team members, fostering
collaboration, and driving accountability. Ability to work
strategically and independently while thriving in a collaborative,
fast-paced setting. Work Environment / Physical Demands Primarily
office-based with tasks involving regulatory documentation,
strategy development, and cross-functional/global coordination.
Requires prolonged periods of computer use for drafting, reviewing,
compiling, and reporting on CMC documents and submissions. May
involve lifting office materials up to 15 pounds. Ability to
navigate standard office environments and travel occasionally for
regulatory meetings, health authority interactions, inspections, or
conferences (as needed). Why Capricor? Capricor Therapeutics, a
trailblazer in cell and exosome therapy, is dedicated to redefining
standards of care with innovative treatments rooted in scientific
excellence. Guided by integrity and a passion for patient-centered
impact, our team is shaping a brighter future for healthcare. Join
us and contribute to a mission-driven group that’s transforming
lives with every breakthrough. Come Work With Us! At Capricor,
you’ll thrive in a collaborative environment that nurtures your
professional growth and innovation. Join a dedicated team fueled by
a passion for advancing medical science and transforming patient
lives through our cutting-edge therapies. Please note that Capricor
does not use Skype for interviews or recruiting activities.
Candidates will only be contacted by an official Capricor email
address which is @capricor.com. Additionally, Capricor will never
ask potential employees to send a check or money to the Company for
any reason. Notice to Recruiting Agencies Capricor Therapeutics
does not accept candidate submissions or referrals from recruiting
agencies, staffing firms, or third-party recruiters without
expressed consent from Talent Acquisition management and a prior
written agreement. Agencies that contact hiring managers directly,
solicit business, or submit candidates without this approval will
not be considered for any engagement. All such submissions become
the property of Capricor Therapeutics, and no fees will be paid for
any candidates hired as a result. We appreciate your cooperation
and respect for this policy.
Keywords: Capricor Therapeutics, Laguna Beach , Director, CMC Regulatory Affairs, Science, Research & Development , San Diego, California